| Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles ME Davis, JE Zuckerman, CHJ Choi, D Seligson, A Tolcher, CA Alabi, ... Nature 464 (7291), 1067-1070, 2010 | 3005 | 2010 |
| Virtual histological staining of unlabelled tissue-autofluorescence images via deep learning Y Rivenson, H Wang, Z Wei, K de Haan, Y Zhang, Y Wu, H Günaydın, ... Nature biomedical engineering 3 (6), 466-477, 2019 | 596 | 2019 |
| Targeting kidney mesangium by nanoparticles of defined size CHJ Choi, JE Zuckerman, P Webster, ME Davis Proceedings of the National Academy of Sciences 108 (16), 6656-6661, 2011 | 518 | 2011 |
| Clinical experiences with systemically administered siRNA-based therapeutics in cancer JE Zuckerman, ME Davis Nature reviews Drug discovery 14 (12), 843-856, 2015 | 427 | 2015 |
| Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane JE Zuckerman, CHJ Choi, H Han, ME Davis Proceedings of the National Academy of Sciences 109 (8), 3137-3142, 2012 | 419 | 2012 |
| Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA JE Zuckerman, I Gritli, A Tolcher, JD Heidel, D Lim, R Morgan, ... Proceedings of the National Academy of Sciences 111 (31), 11449-11454, 2014 | 412 | 2014 |
| Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032 JN Søndergaard, R Nazarian, Q Wang, D Guo, T Hsueh, S Mok, ... Journal of translational medicine 8, 1-11, 2010 | 274 | 2010 |
| Deep learning-based transformation of H&E stained tissues into special stains K de Haan, Y Zhang, JE Zuckerman, T Liu, AE Sisk, MFP Diaz, KY Jen, ... Nature communications 12 (1), 1-13, 2021 | 218 | 2021 |
| Multicenter clinicopathologic correlation of kidney biopsies performed in COVID-19 patients presenting with acute kidney injury or proteinuria S Akilesh, CC Nast, M Yamashita, K Henriksen, V Charu, ML Troxell, ... American Journal of Kidney Diseases 77 (1), 82-93. e1, 2021 | 216 | 2021 |
| CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing AJ Clark, DT Wiley, JE Zuckerman, P Webster, J Chao, J Lin, Y Yen, ... Proceedings of the National Academy of Sciences 113 (14), 3850-3854, 2016 | 179 | 2016 |
| Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle S Eliasof, D Lazarus, CG Peters, RI Case, RO Cole, J Hwang, T Schluep, ... Proceedings of the National Academy of Sciences 110 (37), 15127-15132, 2013 | 155 | 2013 |
| Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels LJ Siskind, L Feinstein, T Yu, JS Davis, D Jones, J Choi, JE Zuckerman, ... Journal of Biological Chemistry 283 (11), 6622-6630, 2008 | 151 | 2008 |
| A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19) RM May, C Cassol, A Hannoudi, CP Larsen, EV Lerma, RS Haun, ... Kidney international 100 (6), 1303-1315, 2021 | 137 | 2021 |
| Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice W Zhang, A Miikeda, J Zuckerman, X Jia, S Charugundla, Z Zhou, ... Scientific Reports 11 (1), 518, 2021 | 103 | 2021 |
| Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth MA Rahman, ARMR Amin, X Wang, JE Zuckerman, CHJ Choi, B Zhou, ... Journal of Controlled Release 159 (3), 384-392, 2012 | 101 | 2012 |
| siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA JE Zuckerman, A Gale, P Wu, R Ma, ME Davis Nucleic acid therapeutics 25 (2), 53-64, 2015 | 82 | 2015 |
| Targeting therapeutics to the glomerulus with nanoparticles JE Zuckerman, ME Davis Advances in chronic kidney disease 20 (6), 500-507, 2013 | 82 | 2013 |
| Automated computational detection of interstitial fibrosis, tubular atrophy, and glomerulosclerosis B Ginley, KY Jen, SS Han, L Rodrigues, S Jain, AB Fogo, J Zuckerman, ... Journal of the American Society of Nephrology 32 (4), 837-850, 2021 | 75 | 2021 |
| siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide JE Zuckerman, T Hsueh, RC Koya, ME Davis, A Ribas Journal of investigative dermatology 131 (2), 453-460, 2011 | 50 | 2011 |
| Store–operated Ca2+ channels in mesangial cells inhibit matrix protein expression P Wu, Y Wang, ME Davis, JE Zuckerman, S Chaudhari, M Begg, R Ma Journal of the American Society of Nephrology 26 (11), 2691-2702, 2015 | 47 | 2015 |
